Publishing coronavirology: Peering into peer(less?) review
dc.contributor.author | Pederson, Thoru | |
dc.date | 2022-08-11T08:08:09.000 | |
dc.date.accessioned | 2022-08-23T15:44:27Z | |
dc.date.available | 2022-08-23T15:44:27Z | |
dc.date.issued | 2020-08-12 | |
dc.date.submitted | 2020-08-27 | |
dc.identifier.citation | <p>Pederson T. Publishing coronavirology: Peering into peer(less?) review. FASEB J. 2020 Aug;34(8):9825-9827. doi: 10.1096/fj.202001592. PMID: 32803811; PMCID: PMC7436724. <a href="https://doi.org/10.1096/fj.202001592">Link to article on publisher's site</a></p> | |
dc.identifier.issn | 0892-6638 (Linking) | |
dc.identifier.doi | 10.1096/fj.202001592 | |
dc.identifier.pmid | 32803811 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14038/27315 | |
dc.description.abstract | This editorial discusses two controversial recent publications in the fast‐moving SARS‐CoV‐2 field and the role of peer review. | |
dc.language.iso | en_US | |
dc.relation | <p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=32803811&dopt=Abstract">Link to Article in PubMed</a></p> | |
dc.relation.url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7436724/ | |
dc.subject | COVID-19 | |
dc.subject | SARS‐CoV‐2 | |
dc.subject | research | |
dc.subject | scientific journals | |
dc.subject | fast-track publication policy | |
dc.subject | peer review | |
dc.subject | Infectious Disease | |
dc.subject | Research Methods in Life Sciences | |
dc.subject | Scholarly Communication | |
dc.subject | Scholarly Publishing | |
dc.subject | Virus Diseases | |
dc.title | Publishing coronavirology: Peering into peer(less?) review | |
dc.type | Editorial | |
dc.source.journaltitle | FASEB journal : official publication of the Federation of American Societies for Experimental Biology | |
dc.source.volume | 34 | |
dc.source.issue | 8 | |
dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/covid19/100 | |
dc.identifier.contextkey | 19160739 | |
html.description.abstract | <p>This editorial discusses two controversial recent publications in the fast‐moving SARS‐CoV‐2 field and the role of peer review.</p> | |
dc.identifier.submissionpath | covid19/100 | |
dc.contributor.department | Department of Biochemistry and Molecular Pharmacology | |
dc.source.pages | 9825-9827 |